Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II

Journal of Clinical Investigation

Volumn 91, Issue 5, 1993, Pages 2268-2274

  Itoh, Hiroshi ^a   Mukoyama, Masashi ^a   Pratt, Richard E ^a   Gibbons, Gary H ^a   Dzau, Victor J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II; Antisense oligonucleotides; Growth factors; Hyperplasia; Hypertrophy

Indexed keywords

ANGIOTENSIN; ANTISENSE OLIGODEOXYNUCLEOTIDE; BASIC FIBROBLAST GROWTH FACTOR; DNA; GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CELL GROWTH; CONTROLLED STUDY; DNA SYNTHESIS; GENE INDUCTION; GROWTH REGULATION; NONHUMAN; ONCOGENE C FOS; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN INDUCTION; RAT; VASCULAR SMOOTH MUSCLE;

3T3 CELLS; AMINO ACID SEQUENCE; ANGIOTENSIN II; ANIMAL; AORTA; CELL DIVISION; CELLS, CULTURED; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; GENES, FOS; GENES, JUN; GENES, MYC; HUMAN; KINETICS; MICE; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH, VASCULAR; OLIGODEOXYRIBONUCLEOTIDES; OLIGONUCLEOTIDES, ANTISENSE; PLATELET-DERIVED GROWTH FACTOR; RATS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSFORMING GROWTH FACTOR BETA;

EID: 0027160183     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI116454     Document Type: Article

References (39)

1. Ross, R. 1986. The pathogenesis of atherosclerosis: an update. N. Engl. J. Med. 314:488-500.
2. Dzau, V. J., and G. H. Gibbons. 1988. Cell biology of vascular hypertrophy in systemic hypertension. Am. J. Cardiol 62:30G-35G.
3. Owens, G. K. 1989. Control of hypertrophie versus hyperplastic growth of vascular smooth muscle cells. Am. J. Physiol. 257:H1755-H1765.
4. Sarzani, R., P. Brecher, and A. V. Chobanian. 1989. Growth factor expression in aorta of normotensive and hypertensive rats. J. Clin. Invest. 83:1404-1408.
5. Barrett, T. B., and E. P. Benditt. 1988. Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall. Proc. Natl. Acad. Sci. USA. 85:2810-2814.
6. Ferns, G. A. A., E. W. Raines, K. H. Sprugel, A. S. Motani, M. A. Reidy, and R. Ross. 1991. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science (Wash. DC). 253:1129-1132.
7. Majesky, M. W., V. Lindner, D. R. Twardzik, S. M. Schwartz, and M. A. Reidy. 1991. Production of transforming growth factor β1 during repair of arterial injury. J. Clin. Invest. 88:904-910.
8. Lindner, V., D. A. Lappi, A. Baird, R. A. Majack, and M. A. Reidy. 1991. Role of basic fibroblast growth factor in vascular lesion formation. Circ. Res. 68:106-113.
9. Powell, J. S., J. P. Clozel, R. K. M. Muller, H. Kuhn, F. Hefti, M. Hosang, and H. R. Baumgartner. 1989. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science (Wash. DC). 245:186-188.
10. Daemen, M. J. A. P., D. M. Lombardi, F. T. Bosman, and S. M. Schwartz. 1991. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ. Res. 68:450-456.
11. Campbell-Boswell, M., and L. A. Robertson, Jr. 1981. Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro. Exp. Mol. Pathol. 35:265-276.
12. Geisterfer, A. A. T., M. J. Peach, and G. K. Owens. 1988. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ. Res. 62:749-756.
13. Dzau, V. J. 1986. Significance of vascular renin-angiotensin pathways. Hypertension (Dallas). 8:553-559.
14. Dzau, V. J. 1988. Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation. 77(Suppl. I):I-4-I-13.
15. Itoh, H., R. E. Pratt, and V. J. Dzau. 1990. Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. J. Clin. Invest. 86:1690-1697.
16. Naftilan, A. J., R. E. Pratt, C. S. Eldridge, H. L. Lin, and V. J. Dzau. 1989. Angiotensin II induces c-fos expression in smooth muscle via transcriptional control. Hypertension (Dallas). 13:706-711.
17. Itoh, H., R. E. Pratt, and V. J. Dzau. 1991. Interaction of atrial natriuretic polypeptide and angiotensin II on protooncogene expression and vascular cell growth. Biochem. Biophys. Res. Commun. 176:1601-1609.
18. Naftilan, A. J., R. E. Pratt, and V. J. Dzau. 1989. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J. Clin. Invest. 83:1419-1424.
19. Gibbons, G. H., R. E. Pratt, and V. J. Dzau. 1992. Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor expression determines growth response to angiotensin II. J. Clin. Invest. 90:456-461.
20. Owens, G. K., and L. G. Thompson. 1986. Expression of smooth muscle-specific isoactin in cultured vascular smooth muscle cells: relationship between growth and cytodifferentiation. J. Cell Biol. 102:343-352.
21. Sporn, M. B., A. B. Roberts, L. M. Wakefield, and B. de Crombrugghe. 1987. Some recent advances in the chemistry and biology of transforming growth factor-β J. Cell Biol. 105:1039-1045.
22. Burgess, W. H., and T. Maciag. 1989. The heparin-binding (fibroblast) growth factor family of proteins. Annu. Rev. Biochem. 58:575-606.
23. Betsholtz, C., A. Johnsson, C. H. Heldin, B. Westermark, P. Lind, M. S. Urdea, R. Eddy, T. B. Shows, K. Philpott, A. L. Mellor, et al. 1986. cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumor cell lines. Nature (Lond.). 320:695-699.
24. Itoh, H., R. E. Pratt, and V. J. Dzau. 1990. Antisense oligonucleotides complementary to PDGF mRNA attenuate angiotensin Il-induced vascular hypertrophy. Hypertension (Dallas). 16:325. (Abstr.)
25. Danielpour, D., L. L. Dart, K. C. Flanders, A. B. Roberts, and M. B. Sporn. 1989. Immunodetection and quantitation of the two forms of transforming growth factor-β (TGF-β1 and TGF-β2) secreted by cells in culture. J. Cell. Physiol. 138:79-86.
26. Klagsbrun, M., J. Sasse, R. Sullivan, and J. A. Smith. 1986. Human tumor cells synthesize an endothelial cell growth factor that is structurally related to basic fibroblast growth factor. Proc. Nutl. Acad. Sci. USA. 83:2448-2452.
27. Schweigerer, L., G. Neufeld, J. Friedman, J. A. Abraham, J. C. Fiddes, and D. Gospodarowicz. 1987. Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature (Lond.). 325:257-259.
28. Itoh, M., M. Mukoyama, R. E. Pratt, and V. J. Dzau. 1992. Specific blockade of basic fibroblast growth factor gene expression in endothelial cells by antisense oligonucleotide. Biochem. Biophys. Res. Commun. 188:1205-1213.
29. Battegay, E. J., E. W. Rames, R. A. Seifert, D. F. Bowen-Pope, and R. Ross. 1990. TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell. 63:515-524.
30. Majack, R. A., M. W. Majesky, and L. V. Goodman. 1990. Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-β. J. Cell Biol. 111:239-247.
31. Owens, G. K., A. A. T. Geisterfer, Y. W-H. Yang, and A. Komoriya. 1988. Transforming growth factor β-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells. J. Cell Biol. 107:771-780.
32. Koibuchi, Y., G. H. Gibbons, W. Lee, and R. E. Pratt. 1993. Role of TGF-β activation in the cellular growth to Ang II. Hypertension (Dallas). In press.
33. Vlodavsky, I., R. Fridman, R. Sullivan, J. Sasse, and M. Klagsbrun. 1987. Aortic endothelial cells synthesize basic fibroblast growth factor which remains cell associated and platelet-derived growth factor-like protein which is secreted. J. Cell. Physiol. 131:402-408.
34. Powell, P. P., and M. Klagsbrun. 1991. Three forms of rat basic fibroblast growth factor are made from single mRNA and localize to the nucleus. J. Cell. Physiol. 148:202-210.
35. Rogelj, S., R. A. Weinberg, P. Fanning, and M. Klagsbrun. Basic fibroblast growth factor fused to a signal peptide transforms cells. Nature (Lond.). 331:173-175.
36. Mignatti, P., T. Morimoto, and D. B. Rifkin. 1991. Basic fibroblast growth factor released by single, isolated cells stimulates their migration in an autocrine manner. Proc. Natl. Acad. Sci. USA. 88:11007-11011.
37. Frater-Schroder, M., G. Muller, W. Birchmeier, and P. Bohlen. 1986. Transforming growth factor-β inhibits endothelial cell proliferation. Biochem. Biophys. Res. Commun. 137:295-302.
38. Saksela, O., D. Moscatelli, D. B. Rifkin. 1987. The opposing effects of basic fibroblast growth factor and transforming growth factor-β on the regulation of plasminogen activator activity in capillary endothelial cells. J. Cell. Biol. 105:957-963.
39. Gibbons, G. H., R. E. Pratt, and V. J. Dzau. 1991. Induction of autocrine transforming growth factor-β1 modulates vascular myocyte growth induced by angiotensin II but not basic fibroblast growth factor. J. Cell Biochem. 15C(Suppl.):134.